세계의 약물유전체학 시장 기회와 전략(-2032년)

“Pharmacogenomics Global Market Opportunities And Strategies To 2032 ” from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global pharmacogenomics market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis

Where is the largest and fastest-growing market for pharmacogenomics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? “The pharmacogenomics market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider pharmacogenomics market; and compares it with other markets.

The report covers the following chapters:

• Introduction And Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the pharmacogenomics market.

• Key Trends - Highlights the major trends shaping the global pharmacogenomics market. This section also highlights likely future developments in the market.

• Macro-Economic Scenario - The report provides an analysis of the impact of the COVID-19 pandemic, the key effects of the Russia-Ukraine war in the region and worldwide, and the impact of rising inflation on global and regional markets, providing strategic insights for businesses in the pharmacogenomics market.

• Global Market Size And Growth - Global historic (2017-2022) and forecast (2022-2027, 2032F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.

• Regional Analysis - Historic (2017-2022) and forecast (2022-2027, 2032F) market values and growth and market share comparison by region.

• Market Segmentation - Contains the market values (2017-2032) and analysis for each segment by technology, by application and by end user in the market.

• Regional Market Size And Growth - Regional market size (2022), historic (2017-2022) and forecast (2022-2027, 2032F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa, together with major countries within each region.

• Competitive Landscape - Details on the competitive landscape of the market, estimated market share and company profiles of the leading players.

• Key Mergers And Acquisitions - Information on recent mergers and acquisitions in the market covered by the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.

• Market Opportunities And Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.

• Conclusions And Recommendations - This section includes recommendations for pharmacogenomics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.

• Appendix - This section includes details on the NAICS codes covered, abbreviations and currency codes used in this report.

Scope

Markets Covered:

• 1) By Technology: Next Generation Sequencing; Polymerase Chain Reaction; Gel Electrophoresis; Mass Spectrometry; Microarray; Other Technologies
• 2) By Application: Neurological Diseases; Infectious Diseases; Oncology; Cardiovascular Diseases; Pain Management; Other Applications
• 3) By End User: Hospitals and Clinics; Research Institutions; Academic Institutes; Other End Users
• Companies Mentioned: Illumina Inc; Eurofins Scientific; Myriad Genetics Inc; PerkinElmer Inc; Centogene N.V.
• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; pharmacogenomics indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Table Of Contents

3. List Of Figures

4. List Of Tables

5. Report Structure

6. Introduction And Market Characteristics

• 6.1. General Market Definition
• 6.2. Summary
• 6.3. Pharmacogenomics Market Definition And Segmentations
• 6.4. Market Segmentation By Technology
  • 6.4.1. Next Generation Sequencing
  • 6.4.2. Polymerase Chain Reaction
  • 6.4.3. Gel Electrophoresis
  • 6.4.4. Mass Spectrometry
  • 6.4.5. Microarray
  • 6.4.6. Other Technologies
• 6.5. Market Segmentation By Application
  • 6.5.1. Neurological Diseases
  • 6.5.2. Infectious Diseases
  • 6.5.3. Oncology
  • 6.5.4. Cardiovascular Diseases
  • 6.5.5. Pain Management
  • 6.5.6. Other Applications
• 6.6. Market Segmentation By End User
  • 6.6.1. Hospitals And Clinics
  • 6.6.2. Research Institutions
  • 6.6.3. Academic Institutes
  • 6.6.4. Other End Users

7. Major Market Trends

• 7.1. Launch Of Genome Editing Solution For Deeper Analysis Of Advanced Therapies
• 7.2. Focus On Integration Of Artificial Intelligence (AI) In Genomics To Analyze Genetic Data
• 7.3. Growing Advancements In Metagenomics
• 7.4. Strategic Partnerships And Collaborations Among Market Players
• 7.5. Introduction Of Three-Dimensional (3D) Genomics To Study Influences On Gene Expression And Function
• 7.6. New Product Innovations With Focus On Infectious Diseases And Gene Editing
• 7.7. Development Of Psychotropic Pharmacogenomics Test For Informed Decisions

8. Pharmacogenomics Market - Macro-Economic Scenario

• 8.1. COVID-19 Impact On The Pharmacogenomics Market
• 8.2. Impact Of The War In Ukraine On The Pharmacogenomics Market
• 8.3. Impact Of High Inflation On The Pharmacogenomics Market

9. Global Market Size and Growth

• 9.1. Market Size
• 9.2. Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 9.2.1. Market Drivers 2017 - 2022
  • 9.2.2. Market Restraints 2017 - 2022
• 9.3. Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 9.3.1. Market Drivers 2022 - 2027
  • 9.3.2. Market Restraints 2022 - 2027

10. Global Pharmacogenomics Market Segmentation

• 10.1. Global Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 10.2. Global Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 10.3. Global Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

11. Pharmacogenomics Market, Regional and Country Analysis

• 11.1. Global Pharmacogenomics Market, By Region, Historic and Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 11.2. Global Pharmacogenomics Market, By Country, Historic and Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

12. Asia-Pacific Market

• 12.1. Summary
• 12.2. Market Overview
  • 12.2.1. Region Information
  • 12.2.2. Market Information
  • 12.2.3. Background Information
  • 12.2.4. Government Initiatives
  • 12.2.5. Regulations
  • 12.2.6. Regulatory Bodies
  • 12.2.7. Major Associations
  • 12.2.8. Taxes Levied
  • 12.2.9. Corporate Tax Structure
  • 12.2.10. Investments
  • 12.2.11. Major Companies
• 12.3. Asia-Pacific Pharmacogenomics Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 12.4. Asia-Pacific Pharmacogenomics Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 12.5. Asia-Pacific Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.6. Asia-Pacific Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.7. Asia-Pacific Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.8. Asia-Pacific Pharmacogenomics Market: Country Analysis
• 12.9. China Market
• 12.10. Summary
• 12.11. Market Overview
  • 12.11.1. Country Information
  • 12.11.2. Market Information
  • 12.11.3. Background Information
  • 12.11.4. Government Initiatives
  • 12.11.5. Regulations
  • 12.11.6. Regulatory Bodies
  • 12.11.7. Major Associations
  • 12.11.8. Taxes Levied
  • 12.11.9. Corporate Tax Structure
  • 12.11.10. Investments
  • 12.11.11. Major Companies
• 12.12. China Pharmacogenomics Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 12.13. China Pharmacogenomics Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 12.14. China Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.15. China Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.16. China Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.17. India Market
• 12.18. India Pharmacogenomics Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 12.19. India Pharmacogenomics Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 12.20. India Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.21. India Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.22. India Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.23. Japan Market
• 12.24. Japan Pharmacogenomics Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 12.25. Japan Pharmacogenomics Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 12.26. Japan Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.27. Japan Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.28. Japan Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.29. Australia Market
• 12.30. Australia Pharmacogenomics Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 12.31. Australia Pharmacogenomics Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 12.32. Australia Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.33. Australia Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.34. Australia Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.35. Indonesia Market
• 12.36. Indonesia Pharmacogenomics Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 12.37. Indonesia Pharmacogenomics Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 12.38. Indonesia Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.39. Indonesia Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.40. Indonesia Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.41. South Korea Market
• 12.42. South Korea Pharmacogenomics Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 12.43. South Korea Pharmacogenomics Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 12.44. South Korea Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.45. South Korea Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.46. South Korea Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

13. Western Europe Market

• 13.1. Summary
• 13.2. Market Overview
  • 13.2.1. Region Information
  • 13.2.2. Market Information
  • 13.2.3. Background Information
  • 13.2.4. Government Initiatives
  • 13.2.5. Regulations
  • 13.2.6. Regulatory Bodies
  • 13.2.7. Major Associations
  • 13.2.8. Taxes Levied
  • 13.2.9. Corporate Tax Structure
  • 13.2.10. Investments
  • 13.2.11. Major Companies
• 13.3. Western Europe Pharmacogenomics Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 13.4. Western Europe Pharmacogenomics Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 13.5. Western Europe Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 13.6. Western Europe Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 13.7. Western Europe Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 13.8. Western Europe Pharmacogenomics Market: Country Analysis
• 13.9. UK Market
• 13.10. UK Pharmacogenomics Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 13.11. UK Pharmacogenomics Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 13.12. UK Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 13.13. UK Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 13.14. UK Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 13.15. Germany Market
• 13.16. Germany Pharmacogenomics Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 13.17. Germany Pharmacogenomics Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 13.18. Germany Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 13.19. Germany Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 13.20. Germany Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 13.21. France Market
• 13.22. France Pharmacogenomics Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 13.23. France Pharmacogenomics Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 13.24. France Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 13.25. France Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 13.26. France Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

14. Eastern Europe Market

• 14.1. Summary
• 14.2. Market Overview
  • 14.2.1. Region Information
  • 14.2.2. Market Information
  • 14.2.3. Background Information
  • 14.2.4. Government Initiatives
  • 14.2.5. Regulations
  • 14.2.6. Regulatory Bodies
  • 14.2.7. Major Associations
  • 14.2.8. Taxes Levied
  • 14.2.9. Corporate Tax Structure
  • 14.2.10. Investment
  • 14.2.11. Major Companies
• 14.3. Eastern Europe Pharmacogenomics Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 14.4. Eastern Europe Pharmacogenomics Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 14.5. Eastern Europe Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 14.6. Eastern Europe Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 14.7. Eastern Europe Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 14.8. Eastern Europe Pharmacogenomics Market: Country Analysis
• 14.9. Russia Market
• 14.10. Russia Pharmacogenomics Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 14.11. Russia Pharmacogenomics Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 14.12. Russia Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 14.13. Russia Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 14.14. Russia Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

15. North America Market

• 15.1. Summary
• 15.2. Market Overview
  • 15.2.1. Region Information
  • 15.2.2. Market Information
  • 15.2.3. Background Information
  • 15.2.4. Government Initiatives
  • 15.2.5. Regulations
  • 15.2.6. Regulatory Bodies
  • 15.2.7. Major Associations
  • 15.2.8. Taxes Levied
  • 15.2.9. Corporate Tax Structure
  • 15.2.10. Investments
  • 15.2.11. Major Companies
• 15.3. North America Pharmacogenomics Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 15.4. North America Pharmacogenomics Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 15.5. North America Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 15.6. North America Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 15.7. North America Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 15.8. North America Pharmacogenomics Market: Country Analysis
• 15.9. USA Market
• 15.10. Summary
• 15.11. Market Overview
  • 15.11.1. Country Information
  • 15.11.2. Market Information
  • 15.11.3. Background Information
  • 15.11.4. Government Initiatives
  • 15.11.5. Regulations
  • 15.11.6. Regulatory Bodies
  • 15.11.7. Major Associations
  • 15.11.8. Taxes Levied
  • 15.11.9. Corporate Tax Structure
  • 15.11.10. Investments
  • 15.11.11. Major Companies
• 15.12. USA Pharmacogenomics Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 15.13. USA Pharmacogenomics Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 15.14. USA Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 15.15. USA Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 15.16. USA Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

16. South America Market

• 16.1. Summary
• 16.2. Market Overview
  • 16.2.1. Region Information
  • 16.2.2. Market Information
  • 16.2.3. Background Information
  • 16.2.4. Government Initiatives
  • 16.2.5. Regulations
  • 16.2.6. Regulatory Bodies
  • 16.2.7. Major Associations
  • 16.2.8. Taxes Levied
  • 16.2.9. Corporate Tax Structure
  • 16.2.10. Investments
  • 16.2.11. Major Companies
• 16.3. South America Pharmacogenomics Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 16.4. South America Pharmacogenomics Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 16.5. South America Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 16.6. South America Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 16.7. South America Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 16.8. South America Pharmacogenomics Market: Country Analysis
• 16.9. Brazil Market
• 16.10. Brazil Pharmacogenomics Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 16.11. Brazil Pharmacogenomics Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 16.12. Brazil Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 16.13. Brazil Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 16.14. Brazil Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

17. Middle East Market

• 17.1. Summary
• 17.2. Market Overview
  • 17.2.1. Region Information
  • 17.2.2. Market Information
  • 17.2.3. Background Information
  • 17.2.4. Government Initiatives
  • 17.2.5. Regulations
  • 17.2.6. Regulatory Bodies
  • 17.2.7. Major Associations
  • 17.2.8. Taxes Levied
  • 17.2.9. Corporate Tax Structure
  • 17.2.10. Investments
  • 17.2.11. Major Companies
• 17.3. Middle East Pharmacogenomics Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 17.4. Middle East Pharmacogenomics Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 17.5. Middle East Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 17.6. Middle East Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 17.7. Middle East Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

18. Africa Market

• 18.1. Summary
• 18.2. Market Overview
  • 18.2.1. Region Information
  • 18.2.2. Market Information
  • 18.2.3. Background Information
  • 18.2.4. Government Initiatives
  • 18.2.5. Regulations
  • 18.2.6. Regulatory Bodies
  • 18.2.7. Major Associations
  • 18.2.8. Taxes Levied
  • 18.2.9. Corporate Tax Structure
  • 18.2.10. Investments
  • 18.2.11. Major Companies
• 18.3. Africa Pharmacogenomics Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 18.4. Africa Pharmacogenomics Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 18.5. Africa Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 18.6. Africa Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 18.7. Africa Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

19. Competitive Landscape And Company Profiles

• 19.1. Company Profiles
• 19.2. Illumina Inc
  • 19.2.1. Company Overview
  • 19.2.2. Products And Services
  • 19.2.3. Business Strategy
  • 19.2.4. Financial Overview
• 19.3. Eurofins Scientific SE
  • 19.3.1. Company Overview
  • 19.3.2. Products And Services
  • 19.3.3. Business Strategy
  • 19.3.4. Financial Overview
• 19.4. Myriad Genetics Inc
  • 19.4.1. Company Overview
  • 19.4.2. Products And Services
  • 19.4.3. Business Strategy
  • 19.4.4. Financial Overview
• 19.5. PerkinElmer Inc
  • 19.5.1. Company Overview
  • 19.5.2. Products And Services
  • 19.5.3. Business Strategy
  • 19.5.4. Financial Overview
• 19.6. Centogene N.V
  • 19.6.1. Company Overview
  • 19.6.2. Products And Services
  • 19.6.3. Business Strategy
  • 19.6.4. Financial Overview

20. Key Mergers And Acquisitions

• 20.1. Genomenon, Inc Acquired Boston Genetics
• 20.2. Incite Health PTY Limited Acquired CNSDose
• 20.3. Moderna Acquired OriCiro Genomics
• 20.4. RetinalGenix Technologies Acquired DNA/GPS
• 20.5. Castle Biosciences, Inc Acquired AltheaDx
• 20.6. LetsGetChecked Announced Acquisition Of Veritas Genetics And Veritas Intercontinental
• 20.7. Element Biosciences Acquired Loop Genomics
• 20.8. Invitae Corporation Acquired YouScript, Inc And Genelex

21. Opportunities And Strategies

• 21.1. Global Pharmacogenomics Market In 2027 - Countries Offering Most New Opportunities
• 21.2. Global Pharmacogenomics Market In 2027 - Segments Offering Most New Opportunities
• 21.3. Global Pharmacogenomics Market In 2027 - Growth Strategies
  • 21.3.1. Market Trend Based Strategies
  • 21.3.2. Competitor Strategies

22. Pharmacogenomics Market, Conclusions And Recommendations

• 22.1. Conclusions
• 22.2. Recommendations
  • 22.2.1. Product
  • 22.2.2. Place
  • 22.2.3. Price
  • 22.2.4. Promotion
  • 22.2.5. People

23. Appendix

• 23.1. Market Data Sources
• 23.2. Research Methodology
• 23.3. Currencies
• 23.4. The Business Research Company
• 23.5. Copyright and Disclaimer